Gap finder

Search review questions

Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Words match anywhere in the field.

Limit to evidence status or GRADE (optional)

1,173 questions in 89 reviews · Neuromuscular

current versions
No studies 302 · 25.7%Ungraded 119 · 10.1%Very low 267 · 22.8%Low 239 · 20.4%Moderate 177 · 15.1%High 69 · 5.9%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

QuestionEffectEvidenceStatus / GRADE
Aerobic exercise vs no training
Quality of life · people with dermatomyositis and polymyositis
Strength training and aerobic exercise training for muscle disease (2019) · Cochrane
no estimate extractedNRNo studies
Aerobic exercise vs no training
Pain · people with dermatomyositis and polymyositis
Strength training and aerobic exercise training for muscle disease (2019) · Cochrane
no estimate extractedNRNo studies
Strength training vs no training
Aerobic capacity · people with myotonic dystrophy
Strength training and aerobic exercise training for muscle disease (2019) · Cochrane
no estimate extractedNRNo studies
Aerobic exercise vs no training
Experienced fatigue · people with dermatomyositis and polymyositis
Strength training and aerobic exercise training for muscle disease (2019) · Cochrane
no estimate extractedNRNo studies
Aerobic exercise vs no training
Adverse effects requiring withdrawal · people with dermatomyositis and polymyositis
Strength training and aerobic exercise training for muscle disease (2019) · Cochrane
no estimate extractedNRVery low
Aerobic exercise vs no training
Muscle strength: hip extensors, knee extensors, ankle dorsiflexors, shoulder abductors and elbow extensors · boys with DMD
Strength training and aerobic exercise training for muscle disease (2019) · Cochrane
no estimate extractedNRVery low
Aerobic exercise vs no training
Aerobic capacity · boys with DMD
Strength training and aerobic exercise training for muscle disease (2019) · Cochrane
no estimate extractedNRVery low
Aerobic exercise vs no training
Time‐scored functional assessments of muscle performance: functional abilities in 3 different dimensions, standing positions and transfers, axial and proximal motor functions and distal motor function · boys with DMD
Strength training and aerobic exercise training for muscle disease (2019) · Cochrane
no estimate extractedNRVery low
Aerobic exercise vs no training
Quality of life · boys with DMD
Strength training and aerobic exercise training for muscle disease (2019) · Cochrane
no estimate extractedNRNo studies
Aerobic exercise vs no training
Pain · boys with DMD
Strength training and aerobic exercise training for muscle disease (2019) · Cochrane
no estimate extractedNRNo studies
Aerobic exercise vs no training
Experienced fatigue · boys with DMD
Strength training and aerobic exercise training for muscle disease (2019) · Cochrane
no estimate extractedNRNo studies
Aerobic exercise vs no training
Adverse effects requiring withdrawal · boys with DMD
Strength training and aerobic exercise training for muscle disease (2019) · Cochrane
no estimate extractedNRVery low
Aerobic exercise vs no training
Muscle strength: maximum voluntary isometric knee extension strength · people with facioscapulohumeral muscular dystrophy
Strength training and aerobic exercise training for muscle disease (2019) · Cochrane
no estimate extractedNRLow
Strength training vs no training
Time‐scored functional assessments of muscle performance · people with myotonic dystrophy
Strength training and aerobic exercise training for muscle disease (2019) · Cochrane
no estimate extractedNRVery low
Aerobic exercise vs no training
Aerobic capacity: VO2 peak · people with facioscapulohumeral muscular dystrophy
Strength training and aerobic exercise training for muscle disease (2019) · Cochrane
no estimate extractedNRLow
Aerobic exercise vs no training
Time‐scored functional assessments of muscle performance: distance walked · people with facioscapulohumeral muscular dystrophy
Strength training and aerobic exercise training for muscle disease (2019) · Cochrane
no estimate extractedNRLow
Aerobic exercise vs no training
Quality of life · people with facioscapulohumeral muscular dystrophy
Strength training and aerobic exercise training for muscle disease (2019) · Cochrane
no estimate extractedNRLow
Aerobic exercise vs no training
Pain Asssesed with a Visual Analogue Scale Scale from 0 to 100 · people with facioscapulohumeral muscular dystrophy
Strength training and aerobic exercise training for muscle disease (2019) · Cochrane
no estimate extractedNRLow
Aerobic exercise vs no training
Experienced fatigue Assesed with Checklist Individual Strength Scale from 7 to 56 · people with facioscapulohumeral muscular dystrophy
Strength training and aerobic exercise training for muscle disease (2019) · Cochrane
no estimate extractedNRLow
Aerobic exercise vs no training
Adverse effects requiring withdrawal · people with facioscapulohumeral muscular dystrophy
Strength training and aerobic exercise training for muscle disease (2019) · Cochrane
no estimate extractedNRLow
Aerobic exercise and strength training vs no training
Muscle strength: the heaviest weight that could be lifted throughout the complete range of movement (1RM test) · people with mitochondrial myopathy
Strength training and aerobic exercise training for muscle disease (2019) · Cochrane
no estimate extractedNRVery low
Aerobic exercise and strength training vs no training
Aerobic capacity: measures of (physical) work capacity · people with mitochondrial myopathy
Strength training and aerobic exercise training for muscle disease (2019) · Cochrane
no estimate extractedNRVery low
Aerobic exercise and strength training vs no training
Aerobic capacity: distance walked until exhaustion · people with mitochondrial myopathy
Strength training and aerobic exercise training for muscle disease (2019) · Cochrane
no estimate extractedNRVery low
Aerobic exercise and strength training vs no training
Time‐scored functional assessments of muscle performance · people with mitochondrial myopathy
Strength training and aerobic exercise training for muscle disease (2019) · Cochrane
no estimate extractedNRNo studies
Strength training vs no training
Quality of life · people with myotonic dystrophy
Strength training and aerobic exercise training for muscle disease (2019) · Cochrane
no estimate extractedNRNo studies
Aerobic exercise and strength training vs no training
Quality of life · people with mitochondrial myopathy
Strength training and aerobic exercise training for muscle disease (2019) · Cochrane
no estimate extractedNRVery low
Aerobic exercise and strength training vs no training
Pain · people with mitochondrial myopathy
Strength training and aerobic exercise training for muscle disease (2019) · Cochrane
no estimate extractedNRNo studies
Aerobic exercise and strength training vs no training
Experienced fatigue · people with mitochondrial myopathy
Strength training and aerobic exercise training for muscle disease (2019) · Cochrane
no estimate extractedNRNo studies
Aerobic exercise and strength training vs no training
Adverse effects requiring withdrawal · people with mitochondrial myopathy
Strength training and aerobic exercise training for muscle disease (2019) · Cochrane
no estimate extractedNRVery low
Aerobic exercise and strength training vs no training
Muscle strength · people with myotonic dystrophy type 1
Strength training and aerobic exercise training for muscle disease (2019) · Cochrane
no estimate extractedNRNo studies
Aerobic exercise and strength training vs no training
Aerobic capacity · people with myotonic dystrophy type 1
Strength training and aerobic exercise training for muscle disease (2019) · Cochrane
no estimate extractedNRNo studies
Aerobic exercise and strength training vs no training
Time‐scored functional assessments of muscle performance: distance walked · people with myotonic dystrophy type 1
Strength training and aerobic exercise training for muscle disease (2019) · Cochrane
no estimate extractedNRVery low
Aerobic exercise and strength training vs no training
Quality of life · people with myotonic dystrophy type 1
Strength training and aerobic exercise training for muscle disease (2019) · Cochrane
no estimate extractedNRNo studies
Aerobic exercise and strength training vs no training
Pain · people with myotonic dystrophy type 1
Strength training and aerobic exercise training for muscle disease (2019) · Cochrane
no estimate extractedNRNo studies
Aerobic exercise and strength training vs no training
Experienced fatigue · people with myotonic dystrophy type 1
Strength training and aerobic exercise training for muscle disease (2019) · Cochrane
no estimate extractedNRNo studies
Strength training vs no training
Pain · people with myotonic dystrophy
Strength training and aerobic exercise training for muscle disease (2019) · Cochrane
no estimate extractedNRNo studies
Aerobic exercise and strength training vs no training
Adverse effects requiring withdrawal · people with myotonic dystrophy type 1
Strength training and aerobic exercise training for muscle disease (2019) · Cochrane
no estimate extractedNRVery low
Aerobic exercise and strength training vs no training
Muscle strength 21 participants (1 RCT) · people with dermatomyositis and polymyositis
Strength training and aerobic exercise training for muscle disease (2019) · Cochrane
no estimate extractedNRVery low
Aerobic exercise and strength training vs no training
Aerobic capacity, expressed in measures of (physical) work capacity · people with dermatomyositis and polymyositis
Strength training and aerobic exercise training for muscle disease (2019) · Cochrane
no estimate extractedNRVery low
Aerobic exercise and strength training vs no training
Aerobic capacity: VO2 max · people with dermatomyositis and polymyositis
Strength training and aerobic exercise training for muscle disease (2019) · Cochrane
no estimate extractedNRVery low
Aerobic exercise and strength training vs no training
Time‐scored functional assessments of muscle performance: muscle performance · people with dermatomyositis and polymyositis
Strength training and aerobic exercise training for muscle disease (2019) · Cochrane
no estimate extractedNRVery low
Aerobic exercise and strength training vs no training
Quality of life · people with dermatomyositis and polymyositis
Strength training and aerobic exercise training for muscle disease (2019) · Cochrane
no estimate extractedNRVery low
Aerobic exercise and strength training vs no training
Pain · people with dermatomyositis and polymyositis
Strength training and aerobic exercise training for muscle disease (2019) · Cochrane
no estimate extractedNRNo studies
Aerobic exercise and strength training vs no training
Experienced fatigue · people with dermatomyositis and polymyositis
Strength training and aerobic exercise training for muscle disease (2019) · Cochrane
no estimate extractedNRNo studies
Aerobic exercise and strength training vs no training
Adverse effects requiring withdrawal · people with dermatomyositis and polymyositis
Strength training and aerobic exercise training for muscle disease (2019) · Cochrane
no estimate extractedNRVery low
Aerobic exercise and strength training vs no training
Muscle strength: MVC quadriceps at rest · people with facioscapulohumeral muscular dystrophy
Strength training and aerobic exercise training for muscle disease (2019) · Cochrane
no estimate extractedNRVery low
Strength training vs no training
Experienced fatigue · people with myotonic dystrophy
Strength training and aerobic exercise training for muscle disease (2019) · Cochrane
no estimate extractedNRNo studies
Aerobic exercise and strength training vs no training
Aerobic capacity · people with facioscapulohumeral muscular dystrophy
Strength training and aerobic exercise training for muscle disease (2019) · Cochrane
no estimate extractedNRVery low
Aerobic exercise and strength training vs no training
Time‐scored functional assessments of muscle performance: distance walked · people with facioscapulohumeral muscular dystrophy
Strength training and aerobic exercise training for muscle disease (2019) · Cochrane
no estimate extractedNRVery low
Aerobic exercise and strength training vs no training
Quality of life · people with facioscapulohumeral muscular dystrophy
Strength training and aerobic exercise training for muscle disease (2019) · Cochrane
no estimate extractedNRVery low